| Literature DB >> 33790801 |
Átila Alexandre Trapé1,2, Jhennyfer Aline Lima Rodrigues1, Letícia Perticarrara Ferezin3, Gustavo Duarte Ferrari3, Elisangela Aparecida da Silva Lizzi4, Vitor Nolasco de Moraes3, Roberta Fernanda da Silva5, Anderson Saranz Zago5, Javier Brazo-Sayavera6, Carlos Roberto Bueno Júnior1,2,3.
Abstract
Associations of endothelial nitric oxide synthase (NOS3) polymorphisms with hypertension and response to exercise training in prehypertensive and hypertensive older adult women remain unclear. This study used a multicomponent program (various capacities and motor skills) in the physical training intervention. It analyzed the influence of NOS3 polymorphisms [-786T > C, 894G > T (Glu298Asp), and intron 4b/a] on the response of blood pressure (BP), nitrite concentration, and physical fitness in older adult women. Fifty-two participants aged between 50 and 80 underwent body mass index, BP, 6-min walk, elbow flexion, and sit and stand-up tests to assess physical fitness. The intervention duration was 12 weeks, twice a week, on non-consecutive days. Each session lasted 90 min, maintaining an intensity between 13 (moderate) and 15 (intense), controlled by the Subjective Effort Perception Scale. Plasma/blood samples were collected to assess nitrite concentration and genotyping. The statistical analysis included Fisher's exact test and linear mixed-effects models. The multicomponent training's positive effect was observed with a similar response in both prehypertensive and hypertensive groups. However, carriers of different genotypes demonstrated different responses to training: the decreases in systolic and diastolic BP and increases in nitrite expected from the physical training were smaller in variant genotype than ancestral genotype carriers, especially in the hypertensive group. At positions -786T > C and Glu298Asp, only the ancestral genotypes showed a decrease in diastolic BP (Δ% = -8.1, and Δ% = -6.5, respectively) and an increase on nitrite (Δ% = 19.1, and Δ% = 24.1, respectively) in the hypertensive group. Our results show that the benefits of a multicomponent training intervention seem to be genotype-dependent. It should be possible to consider genetic variants when selecting an exercise treatment intervention.Entities:
Keywords: aging; exercise training; genotype; nitric oxide; physical activity
Year: 2021 PMID: 33790801 PMCID: PMC8006435 DOI: 10.3389/fphys.2021.566023
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
FIGURE 1Flow chart – study design and sample selection.
Participants’ genotypes distribution.
| Prehypertensive | Hypertensive | |||
| Genotypes | ( | % | ( | % |
| TT | 12 | 46.2 | 13 | 50.0 |
| TC | 13 | 50.0 | 10 | 38.5 |
| CC | 1 | 3.8 | 3 | 11.5 |
| GluGlu | 14 | 53.9 | 16 | 61.6 |
| GluAsp | 11 | 42.3 | 9 | 34.6 |
| AspAsp | 1 | 3.8 | 1 | 3.8 |
| 4b4b | 20 | 76.9 | 15 | 57.7 |
| 4b4a | 6 | 23.1 | 11 | 42.3 |
| 4a4a | 0 | 0 | 0 | 0 |
Effects of multicomponent training on blood pressure, nitrite concentration, and physical fitness in 26 prehypertensive and 26 hypertensive older adult women.
| Prehypertensive (26) | Hypertensive (26) | |||||||
| Baseline | Post | ES | Δ% | Baseline | Post | ES | Δ% | |
| Age (years) | 61.7 (8.3) | 62.2 (7.9) | ||||||
| SBP (mmHg) | 124.1 (8.6) | 117.0(9.4)* | 0.79 | –5.7 | 140.9(14.7)# | 131.2(15.3)* | 0.64 | –6.9 |
| DBP (mmHg) | 80.7 (9.5) | 75.2(7)* | 0.65 | –6.8 | 85.0(8.7)# | 80.3(9.2)* | 0.52 | –5.5 |
| NO2 (nM) | 105.3 (50) | 142.5(78)* | 0.57 | 35.5 | 118.7 (59.6) | 140.5(61.3)* | 0.36 | 18.7 |
| EFT (reps) | 16.9 (3.7) | 20.0(4.3)* | 0.77 | 18.3 | 17.3 (2.9) | 20.2(3.9)* | 0.84 | 16.8 |
| SS (reps) | 14.8 (3.7) | 18.6(5.1)* | 0,85 | 25.7 | 14.1 (3.0) | 17.0(4.4)* | 0.77 | 20.6 |
| 6 min WT (m) | 525.2 (65.6) | 563.6(64)* | 0.59 | 7.3 | 498.5 (57.6) | 555.3(56.1)* | 0.99 | 11.4 |
FIGURE 2Effects of 12 weeks of multicomponent training on systolic blood pressure (SBP) of 26 prehypertensive and 26 hypertensive older adult women with or without variant genotypes for the NOS3 gene at positions –786T > C, 894G > T (Glu298Asp), and intron 4b/a. *p < 0.05 compared with before the intervention (the same group). #p < 0.05 ancestral genotype of the hypertensive group compared with the ancestral genotype of the prehypertensive group (“TT” versus “TT”; “GluGlu” versus “GluGlu”; “4b4b” versus “4b4b”) before the intervention. $p < 0.05 variant genotypes of the hypertensive group compared with the variant genotypes of the prehypertensive group (“TC + CC” versus “TC + CC”; “GluAsp + AspAsp” versus “GluAsp + AspAsp”; “4b4a + 4a4a” versus “4b4a + 4a4a”) before the intervention. &p < 0.05 ancestral genotype of the hypertensive group compared with the ancestral genotype of the prehypertensive group (“TT” versus “TT”; “GluGlu” versus “GluGlu”; “4b4b” versus “4b4b”) after the intervention. %p < 0.05 variant genotypes of the hypertensive group compared with the variant genotypes of the prehypertensive group (“TC + CC” versus “TC + CC”; “GluAsp + AspAsp” versus “GluAsp + AspAsp”; “4b4a + 4a4a” versus “4b4a + 4a4a”) after the intervention. (A) Genotypes for the NOS3 gene at position −786T > C in the prehypertensive group. (B) Genotypes for the NOS3 gene at position 894G > T (Glu298Asp) in the prehypertensive group. (C) genotypes for the NOS3 gene at intron 4b/a in the prehypertensive group. (D) Genotypes for the NOS3 gene at position −786T > C in the hypertensive group. (E) Genotypes for the NOS3 gene at position 894G > T (Glu298Asp) in the hypertensive group. (F) Genotypes for the NOS3 gene at intron 4b/a in the hypertensive group. Linear mixed-effects models.
FIGURE 3Effects of 12 weeks of multicomponent training on diastolic blood pressure (DBP) of 26 prehypertensive and 26 hypertensive older adult women with or without variant genotypes for the NOS3 gene at positions –786T > C, 894G > T (Glu298Asp), and intron 4b/a. *p < 0.05 compared with before the intervention (the same group). #p < 0.05 ancestral genotype of the hypertensive group compared with the ancestral genotype of the prehypertensive group (“TT” versus “TT”; “GluGlu” versus “GluGlu”) before the intervention. &p < 0.05 ancestral genotype of the hypertensive group compared with the ancestral genotype of the prehypertensive group (“TT“versus “TT”; “GluGlu” versus “GluGlu”) after the intervention. (A) Genotypes for the NOS3 gene at position −786T > C in the prehypertensive group. (B) Genotypes for the NOS3 gene at position 894G > T (Glu298Asp) in the prehypertensive group. (C) genotypes for the NOS3 gene at intron 4b/a in the prehypertensive group. (D) Genotypes for the NOS3 gene at position −786T > C in the hypertensive group. (E) Genotypes for the NOS3 gene at position 894G > T (Glu298Asp) in the hypertensive group. (F) Genotypes for the NOS3 gene at intron 4b/a in the hypertensive group. Linear mixed-effects models.
FIGURE 4Effects of 12 weeks of multicomponent training on nitrite concentration (NO2) of 26 prehypertensive and 26 hypertensive older adult women with or without the variant genotypes for the NOS3 gene at positions –786T > C, 894G > T (Glu298Asp), and intron 4b/a. *p < 0.05 compared with the before intervention (the same group). (A) Genotypes for the NOS3 gene at position −786T > C in the prehypertensive group. (B) Genotypes for the NOS3 gene at position 894G > T (Glu298Asp) in the prehypertensive group. (C) Genotypes for the NOS3 gene at intron 4b/a in the prehypertensive group. (D) Genotypes for the NOS3 gene at position −786T > C in the hypertensive group. (E) Genotypes for the NOS3 gene at position 894G > T (Glu298Asp) in the hypertensive group. (F) Genotypes for the NOS3 gene at intron 4b/a in the hypertensive group. Linear mixed-effects models.
Effects of 12 weeks of multicomponent training on physical fitness of 26 prehypertensive and 26 hypertensive older adult women with or without variant genotypes for the NOS3 gene at position −786T > C, 894G > T (Glu298Asp) and intron 4b/a.
| Prehypertensive | Hypertensive | |||||||||||||||
| TT (12) | TC + CC (14) | TT (13) | TC + CC (13) | |||||||||||||
| Baseline | Post | ES | Δ% | Baseline | Post | ES | Δ% | Baseline | Post | ES | Δ% | Baseline | Post | ES | Δ% | |
| SBP (mmHg) | 123.3 (8.5) | 114.6 (6.0) | 1.18 | –7.1 | 124.9 (9.0) | 119.0 (11.3) | 0.58 | –4.7 | 139.5 (9.9) | 125.7 (7.4) | 1.58 | –9.9 | 142.2 (18.8) | 136.0 (19.5) | 0.32 | –4.4 |
| DBP (mmHg) | 79.3 (11.4) | 72.3 (6.6) | 0.75 | –8.8 | 81.8 (7.8) | 77.8 (6.4) | 0.56 | –4.9 | 86.1 (7.4) | 79.1 (6.4) | 1.01 | –8.1 | 83.9 (10.1) | 81.5 (11.5) | 0.22 | –2.9 |
| NO2 (nM) | 102.1 (53.1) | 139.7 (95.0) | 0.48 | 36.8 | 108.0 (49.1) | 144.8 (63.7) | 0.65 | 34.1 | 133.8 (64.9) | 159.4 (71.9) | 0.37 | 19.1 | 103.6 (52.0) | 121.6 (43.3) | 0.38 | 17.4 |
| EFT (reps) | 16.1 (3.2) | 19.0(4.1)* | 0.79 | 18.0 | 17.6 (4.0) | 20.9(4.4)* | 0.78 | 18.8 | 16.9 (3.0) | 20.1(3.1)* | 1.04 | 18.9 | 17.7 (2.7) | 20.2(4.8)* | 0.64 | 14.1 |
| SS (reps) | 15.1 (4.7) | 18.8(6.1)* | 0.68 | 24.5 | 14.6 (2.7) | 18.4(4.4)* | 1.04 | 26.0 | 13.1 (1.6) | 17.4(4.5)* | 1.27 | 32.8 | 15.1 (3.7) | 16.5 (4.3) | 0.35 | 9.3 |
| 6 min WT (m) | 531.0 (78.8) | 573.5(83)* | 0.53 | 8.0 | 520.3 (54.5) | 555.1(43.3)* | 0.71 | 6.7 | 485.9 (56.1) | 544.9(66.0)* | 1.78 | 12.1 | 511.0 (58.6) | 565.8(44.2)* | 1.06 | 10.7 |
| SBP (mmHg) | 126.1 (8.8) | 117.4 (6.8) | 1.10 | –6.9 | 121.8 (8.2) | 116.4 (12.0) | 0.53 | –4.4 | 140.8 (12.4) | 130.3 (15.1) | 0.76 | –7.5 | 140.9 (18.7) | 132.6 (16.2) | 0.47 | –5.9 |
| DBP (mmHg) | 81.1 (11.0) | 74.6 (7.3) | 0.69 | –8.0 | 80.1 (7.9) | 76.0 (6.8) | 0.56 | –5.1 | 86.5 (7.6) | 80.9 (10.1) | 0.63 | –6.5 | 82.5 (10.2) | 79.4 (7.9) | 0.34 | –3.8 |
| NO2 (nM) | 100.4 (52.2) | 140.3 (92.6) | 0.53 | 39.7 | 110.9 (48.9) | 145.0 (60.8) | 0.62 | 30.7 | 132.2 (69.9) | 164.0 (66.2) | 0.47 | 24.1 | 97.0 (29.7) | 102.8 (23.9) | 0.22 | 6.0 |
| EFT (reps) | 17.4 (3.3) | 20.2(4.8)* | 0.68 | 16.1 | 16.3 (4.1) | 19.8(3.9)* | 0.87 | 21.5 | 17.5 (3.0) | 20.6(3.8)* | 0.91 | 17.7 | 16.9 (2.7) | 19.5(4.2)* | 0.74 | 15.4 |
| SS (reps) | 16.4 (3.9) | 20.0(5.5)* | 0.76 | 22.0 | 13.0 (2.6) | 16.9(4.4)* | 1.08 | 30.0 | 14.4 (3.1) | 17.4(4.1)* | 0.83 | 20.8 | 13.5 (2.9) | 16.2(4.8)* | 0.68 | 20.0 |
| 6 min WT (m) | 536.9 (77.6) | 574.0(78.8)* | 0.47 | 6.9 | 511.6 (48.0) | 551.6(41.0)* | 0.90 | 7.8 | 496.5 (50.1) | 551.9(55.5)* | 1.05 | 11.2 | 501.6 (70.8) | 560.9(59.5)* | 0.91 | 12.0 |
| SBP (mmHg) | 123.7 (7.9) | 115.8 (9.8) | 0.89 | –6.4 | 125.5 (11.4) | 120.8 (7.0) | 0.50 | –3.7 | 140.5 (11.7) | 128.3 (12.0) | 1.03 | –8.7 | 141.3 (18.8) | 135.2 (18.7) | 0.33 | –4.3 |
| DBP (mmHg) | 79.9 (9.6) | 74.1 (7.1) | 0.69 | –7.3 | 83.2 (9.7) | 79.2 (5.1) | 0.52 | –4.8 | 85.3 (8.0) | 79.1 (6.7) | 0.84 | –7.3 | 84.6 (10.0) | 81.9 (12.0) | 0.24 | –3.2 |
| NO2 (nM) | 98.7 (44.2) | 136.1 (75.5) | 0.60 | 37.9 | 127.2 (65.9) | 163.7 (89.8) | 0.46 | 28.7 | 111.7 (59.5) | 135.3 (67.5) | 0.37 | 21.1 | 128.2 (61.3) | 147.5 (54.0) | 0.33 | 15.1 |
| EFT (reps) | 16.4 (3.6) | 19.8(3.9)* | 0.91 | 20.7 | 18.7 (3.8) | 20.8 (5.7) | 0.43 | 11.2 | 17.3 (2.2) | 19.7(3.2)* | 0.87 | 13.9 | 17.3 (3.7) | 20.7(4.8)* | 0.79 | 19.7 |
| SS (reps) | 14.5 (3.9) | 18.5(5.4)* | 0.85 | 27.6 | 16.0 (3.1) | 18.8(4.6)* | 0.71 | 17.5 | 13.1 (1.9) | 16.6(4.4)* | 1.03 | 26.7 | 15.4 (3.7) | 17.5(4.4)* | 0.52 | 13.6 |
| 6 min WT (m) | 517.2 (69.8) | 561.0(70.8)* | 0.62 | 8.5 | 551.9 (43.8) | 572.4 (36.6) | 0.51 | 3.7 | 501.8 (61.8) | 553.7(51.8)* | 0.91 | 10.3 | 494.0 (53.9) | 557.5(64.0)* | 1.07 | 12.9 |